Optimer Pharmaceuticals (OPTR) Reports Q1 EPS of $1.04, Up $1.43 Y/Y
Tweet
Share
E-mailGet Alerts OPTR Hot Sheet
Price: $12.78 --0%
Financial Fact:
Interest income and other, net: 249.12K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest income and other, net: 249.12K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q1 EPS of $1.04, versus ($0.39) last year. Revenue for the quarter came in at $69.28 million, versus $297.44 thousand last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Stardust Power (SDST) Tops Q2 EPS by 1c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
